Develops AI-enhanced electrocardiogram (AI-ECG) solutions for cardiac diagnostics. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
An average decline of 33% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 1,695× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 3% of them.
Analysts' average target sits 12% below today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
The stock has been running stronger than the market lately.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $4K a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 15 buys and 1 sell. Management buying with its own money is usually read as a good sign.
A loss of $9.1M against $4K in annual sales. And on top of that, sales fell from the year before.
The stock trades 12% above the average analyst price target.
On our five-subject report card, HSCS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: HSCS is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Not covered, because the filings we hold do not carry it: the revenue breakdown.